- Home
- VERV vs DFDV Comparison
VERV vs DFDV Comparison
Compare VERV & DFDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- DFDV
- Stock Information
- Founded
- VERV 2018
- DFDV 2018
- Country
- VERV United States
- DFDV United States
- Employees
- VERV N/A
- DFDV N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- DFDV Finance: Consumer Services
- Sector
- VERV Health Care
- DFDV Finance
- Exchange
- VERV Nasdaq
- DFDV Nasdaq
- Market Cap
- VERV 384.2M
- DFDV 340.6M
- IPO Year
- VERV 2021
- DFDV N/A
- Fundamental
- Price
- VERV $11.06
- DFDV $24.14
- Analyst Decision
- VERV Buy
- DFDV Buy
- Analyst Count
- VERV 9
- DFDV 1
- Target Price
- VERV $14.75
- DFDV $45.00
- AVG Volume (30 Days)
- VERV 7.8M
- DFDV 2.1M
- Earning Date
- VERV 08-07-2025
- DFDV 07-01-2025
- Dividend Yield
- VERV N/A
- DFDV N/A
- EPS Growth
- VERV N/A
- DFDV N/A
- EPS
- VERV N/A
- DFDV N/A
- Revenue
- VERV $59,613,000.00
- DFDV $1,975,695.00
- Revenue This Year
- VERV $27.75
- DFDV N/A
- Revenue Next Year
- VERV N/A
- DFDV N/A
- P/E Ratio
- VERV N/A
- DFDV N/A
- Revenue Growth
- VERV 271.44
- DFDV 1.47
- 52 Week Low
- VERV $2.87
- DFDV $0.48
- 52 Week High
- VERV $11.41
- DFDV $53.88
- Technical
- Relative Strength Index (RSI)
- VERV 84.74
- DFDV N/A
- Support Level
- VERV $5.88
- DFDV N/A
- Resistance Level
- VERV $11.41
- DFDV N/A
- Average True Range (ATR)
- VERV 0.49
- DFDV 0.00
- MACD
- VERV 0.64
- DFDV 0.00
- Stochastic Oscillator
- VERV 95.00
- DFDV 0.00
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.
About DFDV DeFi Development Corp. Common Stock
DeFi Development Corp is an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions as well as value-add services to multifamily and commercial property professionals.